companydata.dkPRONOVA BIOPHARMA DANMARK A/S: Financial statements 2013
CVR: 28291736
PRONOVA BIOPHARMA DANMARK A/S (CVR 28291736) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 419,116,611 and a net result of DKK -58,117,455. The profit margin was -13.9%. Equity amounted to DKK 933,700,494. The solvency ratio was 75.3%. The company had 102 employees in the financial year.
- Revenue
- 419,116,611 kr.
- Gross Profit
- 360,391,514 kr.
- Profit/Loss
- -58,117,455 kr.
- Equity
- 933,700,494 kr.
- Total Assets
- 1,240,264,162 kr.
- Employees
- 102
Find more companies like PRONOVA BIOPHARMA DANMARK A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2013
As of June 26, 2013, EY Godkendt Revisionspartnerselskab has been appointed auditor of PRONOVA BIOPHARMA DANMARK A/S.
As of June 26, 2013, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of PRONOVA BIOPHARMA DANMARK A/S.
As of June 26, 2013, Charlotte Berg-Svendsen has joined the board of directors of PRONOVA BIOPHARMA DANMARK A/S.
As of June 26, 2013, Synne Hermansen Røine has left the board of directors of PRONOVA BIOPHARMA DANMARK A/S.
As of June 26, 2013, Ralf Fink is registered as chairman of PRONOVA BIOPHARMA DANMARK A/S.
As of June 26, 2013, Morten Jurs has stepped down as chairman of PRONOVA BIOPHARMA DANMARK A/S.
PRONOVA BIOPHARMA DANMARK A/S has published its annual report for 2012.
About PRONOVA BIOPHARMA DANMARK A/S
PRONOVA BIOPHARMA DANMARK A/S was a Danish company of the type Aktieselskab based in Kalundborg, founded in 2004 and dissolved in 2014. The company was registered under the industry Fremstilling af olier og fedtstoffer. The company has 100 employees. In 2013, the company reported revenue of DKK 419,116,611 and a net result of DKK -58,117,455. Equity amounted to DKK 933,700,494.